Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Sinusitis
•
Primary Care
When would you favor initiation of mepolizumab versus dupilumab for CRSwNP?
Related Questions
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
Do you use AIT as an adjunct therapy in addition to nasal sprays and oral medications for CRS?
Do you counsel a mother to avoid certain food in her diet if she is still breast feeding and her child has confirmed IgE mediated food allergies?
Should in-office oscillometry for lung function measurements be utilized in pediatric patients who are unable to reliably perform spirometry?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
How often do you find a food allergy on a skin test in an EoE patient that when avoided will result in significant resolution of EoE?
How often do you monitor the eosinophil count after initiating anti-IL5 therapy for HAE?
Do you continue shots when a patient transfers under your care and has been receiving less than effective doses of AIT, but insist they have been effective?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
